Quantum Cyber N.V. Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Quantum Cyber N.V. (QUCY) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of -$58.85 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2025-09-26
- Quantum Cyber N.V. other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-12-31 was -$835.36K.
- Quantum Cyber N.V. other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-09-30 was $481.46K, a 651.12% increase year-over-year.
- Quantum Cyber N.V. other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-06-30 was -$90.02K, a 294.84% decline year-over-year.
- Quantum Cyber N.V. other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-03-31 was -$60.57K, a 266.23% decline year-over-year.
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 3 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 6 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 9 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$58.85K 6-K · filed 2025-09-26 | |||
| 2024-12-31 | -$104.56K 20-F · filed 2025-03-31 | |||
| 2024-06-30 | -$62.37K 6-K · filed 2025-09-26 | |||
| 2023-12-31 | -$835.36K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$353.90K derived: sum of 2 quarters · filed 2025-03-31 | -$443.92K derived: sum of 3 quarters · filed 2025-03-31 | -$504.49K 20-F · filed 2025-03-31 |
| 2023-09-30 | $481.46K 6-K · filed 2023-11-16 | $391.44K derived: sum of 2 quarters · filed 2023-11-16 | $330.87K 6-K · filed 2023-11-16 | $233.83K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$90.02K 6-K · filed 2023-08-15 | -$150.60K 6-K · filed 2024-10-18 | -$247.63K derived: sum of 3 quarters · filed 2025-03-31 | -$183.54K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | -$60.57K 6-K · filed 2023-05-16 | -$157.61K derived: sum of 2 quarters · filed 2025-03-31 | -$93.51K derived: sum of 3 quarters · filed 2025-03-31 | -$47.31K derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$97.04K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$32.94K derived: sum of 2 quarters · filed 2025-03-31 | $13.26K derived: sum of 3 quarters · filed 2025-03-31 | $49.70K 20-F · filed 2025-03-31 |
| 2022-09-30 | $64.10K 6-K · filed 2023-11-16 | $110.30K derived: sum of 2 quarters · filed 2023-11-16 | $146.74K 6-K · filed 2023-11-16 | |
| 2022-06-30 | $46.20K 6-K · filed 2023-08-15 | $82.64K 6-K · filed 2023-08-15 | ||
| 2022-03-31 | $36.44K 6-K · filed 2023-05-16 | |||
| 2021-12-31 | $204.97K 20-F · filed 2024-04-09 | |||
| 2021-06-30 | $82.96K 6-K · filed 2022-09-07 | |||
| 2020-12-31 | -$224.66K 20-F · filed 2023-04-07 | |||
| 2019-12-31 | $22.17K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |